Följ
Jérôme Le Pavec
Jérôme Le Pavec
MD, PhD
Verifierad e-postadress på ghpsj.fr
Titel
Citeras av
Citeras av
År
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
S Champiat, O Lambotte, E Barreau, R Belkhir, A Berdelou, F Carbonnel, ...
Annals of Oncology 27 (4), 559-574, 2016
9912016
Anakinra for severe forms of COVID-19: a cohort study
T Huet, H Beaussier, O Voisin, S Jouveshomme, G Dauriat, I Lazareth, ...
The Lancet Rheumatology 2 (7), e393-e400, 2020
6692020
Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension
F Perros, D Montani, P Dorfmüller, I Durand-Gasselin, C Tcherakian, ...
American journal of respiratory and critical care medicine 178 (1), 81-88, 2008
5372008
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
V Cottin, J Le Pavec, G Prévot, H Mal, M Humbert, G Simonneau, ...
European respiratory journal 35 (1), 105-111, 2010
5112010
Immunosuppressive therapy in lupus‐and mixed connective tissue disease–associated pulmonary arterial hypertension: a retrospective analysis of twenty‐three cases
X Jais, D Launay, A Yaici, J Le Pavec, C Tchérakian, O Sitbon, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2008
4302008
Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology
D Montani, L Achouh, P Dorfmüller, J Le Pavec, B Sztrymf, C Tchérakian, ...
Medicine 87 (4), 220-233, 2008
3862008
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled …
F Ader, M Bouscambert-Duchamp, M Hites, N Peiffer-Smadja, J Poissy, ...
The Lancet infectious diseases 22 (2), 209-221, 2022
3372022
Evaluation of readministration of immune checkpoint inhibitors after immune-related adverse events in patients with cancer
A Simonaggio, JM Michot, AL Voisin, J Le Pavec, M Collins, A Lallart, ...
JAMA oncology 5 (9), 1310-1317, 2019
3062019
Portopulmonary hypertension: survival and prognostic factors
J Le Pavec, R Souza, P Herve, D Lebrec, L Savale, C Tcherakian, X Jaïs, ...
American journal of respiratory and critical care medicine 178 (6), 637-643, 2008
2802008
Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension
A Campo, SC Mathai, J Le Pavec, AL Zaiman, LK Hummers, D Boyce, ...
American journal of respiratory and critical care medicine 182 (2), 252-260, 2010
2622010
Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension
A Campo, SC Mathai, J Le Pavec, AL Zaiman, LK Hummers, D Boyce, ...
European Respiratory Journal 38 (2), 359-367, 2011
2062011
HIV-associated pulmonary arterial hypertension: survival and prognostic factors in the modern therapeutic era
B Degano, M Guillaume, L Savale, D Montani, X Jaïs, A Yaici, J Le Pavec, ...
Aids 24 (1), 67-75, 2010
2062010
Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases
R Souza, M Humbert, B Sztrymf, X Jais, A Yaici, J Le Pavec, F Parent, ...
European Respiratory Journal 31 (2), 343-348, 2008
1722008
Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies
J Le Pavec, G Lorillon, X Jaïs, C Tcherakian, S Feuillet, P Dorfmüller, ...
Chest 142 (5), 1150-1157, 2012
1582012
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of …
D Launay, O Sitbon, J Le Pavec, L Savale, C Tcherakian, A Yaïci, ...
Rheumatology 49 (3), 490-500, 2010
1552010
Systemic sclerosis–related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies
J Le Pavec, RE Girgis, N Lechtzin, SC Mathai, D Launay, LK Hummers, ...
Arthritis & Rheumatism 63 (8), 2456-2464, 2011
1532011
Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study
D Montani, B Girerd, X Jaïs, M Levy, D Amar, L Savale, P Dorfmüller, ...
The Lancet Respiratory Medicine 5 (2), 125-134, 2017
1502017
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension
SC Mathai, M Bueso, LK Hummers, D Boyce, N Lechtzin, J Le Pavec, ...
European Respiratory Journal 35 (1), 95-104, 2010
1482010
Systemic sclerosis-associated pulmonary arterial hypertension
J Le Pavec, M Humbert, L Mouthon, PM Hassoun
American journal of respiratory and critical care medicine 181 (12), 1285-1293, 2010
1402010
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension
B Degano, A Yaïci, J Le Pavec, L Savale, X Jaïs, B Camara, M Humbert, ...
European Respiratory Journal 33 (1), 92-98, 2009
1292009
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20